TransMedics Group (TMDX) Stock Forecast & Price Target

$73.81 -21.13 (-22.25%)

As of 11:07 AM Eastern

Compare

TransMedics Group - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Moderate Buy

Based on 12 Analyst Ratings

Sell
0

Hold
6

Buy
6

Based on 12 Wall Street analysts who have issued ratings for TransMedics Group in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 12 analysts, 6 have given a hold rating, and 6 have given a buy rating for TMDX.

Consensus Price Target

$148.78
101.58% Upside

According to the 12 analysts' twelve-month price targets for TransMedics Group, the average price target is $148.78. The highest price target for TMDX is $175.00, while the lowest price target for TMDX is $130.00. The average price target represents a forecasted upside of 101.58% from the current price of $73.81.

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Get the Latest News and Ratings for TMDX and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for TransMedics Group and its competitors.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

TMDX Analyst Ratings Over Time

Type	Current Forecast 5/6/25 to 5/6/26	1 Month Ago 4/6/25 to 4/6/26	3 Months Ago 2/5/25 to 2/5/26	1 Year Ago 5/6/24 to 5/6/25
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	6 Buy rating(s)	7 Buy rating(s)	6 Buy rating(s)	7 Buy rating(s)
Hold	6 Hold rating(s)	5 Hold rating(s)	4 Hold rating(s)	3 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$148.78	$152.33	$144.25	$124.20
Forecasted Upside	101.58% Upside	45.36% Upside	11.30% Upside	33.00% Upside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Moderate Buy

TMDX Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

TMDX Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

TransMedics Group Stock vs. The Competition

Type	TransMedics Group	Medical Companies	S&P 500
Consensus Rating Score	2.58	2.30	2.52
Consensus Rating	Moderate Buy	Hold	Moderate Buy
Predicted Upside	60.47% Upside	938.17% Upside	14.75% Upside
News Sentiment Rating	Neutral News See Recent TMDX News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export

Date	Brokerage	Analyst	Action	Rating	Price Target	Report Date Upside/Downside
5/6/2026	Needham & Company LLC 4 of 5 stars	Mike Matson 2 of 5 stars	Lower Target	Buy	$174.00 ➝ $142.00	+49.58%
5/6/2026	Oppenheimer 3 of 5 stars		Downgrade	Outperform ➝ Market Perform
3/16/2026	TD Cowen 3 of 5 stars		Reiterated Rating	Buy
3/9/2026	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Thomas Stephan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Hold	$115.00 ➝ $130.00	+0.15%
2/25/2026	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Allen Gong Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Neutral	$114.00 ➝ $149.00	+11.81%
2/25/2026	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matt O'Brien Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Overweight	$140.00 ➝ $160.00	+16.60%
12/17/2025	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	William Plovanic Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Buy	$147.00 ➝ $148.00	+20.57%
12/2/2025	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Patrick Wood Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Equal Weight	$123.00 ➝ $135.00	-7.50%
10/13/2025	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Young Li Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	Buy	$145.00	+35.15%
10/8/2025	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Hold (C)

10/6/2025	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Downgrade	Strong-Buy ➝ Hold
9/16/2025	Evercore Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Daniel Markowitz Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	Outperform	$155.00	+35.62%
12/11/2024	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Lower Target	Outperform	$150.00 ➝ $120.00	+73.94%
8/2/2024	Stephens Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	George Sellers Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Overweight	$151.00 ➝ $178.00	+18.98%
6/6/2024	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Initiated Coverage	Overweight	$161.00	+21.03%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 11:03 AM ET.

TMDX Forecast - Frequently Asked Questions

: According to the research reports of 12 Wall Street equities research analysts, the average twelve-month stock price forecast for TransMedics Group is $148.78, with a high forecast of $175.00 and a low forecast of $130.00.
: 12 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for TransMedics Group in the last year. There are currently 6 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" TMDX shares.
: According to analysts, TransMedics Group's stock has a predicted upside of 101.58% based on their 12-month stock forecasts.
: Over the previous 90 days, TransMedics Group's stock had 1 downgrade by analysts.
: TransMedics Group has been rated by research analysts at JPMorgan Chase & Co., Needham & Company LLC, Oppenheimer, Piper Sandler, Stifel Nicolaus, and TD Cowen in the past 90 days.
: Analysts like TransMedics Group more than other "medical" companies. The consensus rating for TransMedics Group is Moderate Buy while the average consensus rating for "medical" companies is Hold. Learn more on how TMDX compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With TransMedics Group Recommendations

This page (NASDAQ:TMDX) was last updated on 5/6/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

TransMedics Group (TMDX) Stock Forecast & Price Target

TransMedics Group - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Consensus Price Target

TMDX Analyst Ratings Over Time

TMDX Analyst Recommendations By Month

TMDX Price Targets by Month

TransMedics Group Stock vs. The Competition

Recent Analyst Forecasts and Stock Ratings

TMDX Forecast - Frequently Asked Questions

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With TransMedics Group Recommendations

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

TransMedics Group (TMDX) Stock Forecast & Price Target

TransMedics Group - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Consensus Price Target

TMDX Analyst Ratings Over Time

TMDX Analyst Recommendations By Month

TMDX Price Targets by Month

TransMedics Group Stock vs. The Competition

Recent Analyst Forecasts and Stock Ratings

TMDX Forecast - Frequently Asked Questions

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With TransMedics Group Recommendations

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools